233 related articles for article (PubMed ID: 8153308)
21. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings.
Frank A; Lefkowitz D; Jaeger S; Gobar L; Sunderland J; Gupta N; Scott W; Mailliard J; Lynch H; Bishop J
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1495-512. PubMed ID: 7635795
[TBL] [Abstract][Full Text] [Related]
22. Advantages of positron emission tomography over computed tomography in mediastinal staging of non-small cell lung cancer.
von Haag DW; Follette DM; Roberts PF; Shelton D; Segel LD; Taylor TM
J Surg Res; 2002 Apr; 103(2):160-4. PubMed ID: 11922730
[TBL] [Abstract][Full Text] [Related]
23. Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease.
Farrell MA; McAdams HP; Herndon JE; Patz EF
Radiology; 2000 Jun; 215(3):886-90. PubMed ID: 10831716
[TBL] [Abstract][Full Text] [Related]
24. Imaging of mediastinal lymph nodes: CT, MR, and FDG PET.
Boiselle PM; Patz EF; Vining DJ; Weissleder R; Shepard JA; McLoud TC
Radiographics; 1998; 18(5):1061-9. PubMed ID: 9747607
[TBL] [Abstract][Full Text] [Related]
25. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma.
Gambhir SS; Hoh CK; Phelps ME; Madar I; Maddahi J
J Nucl Med; 1996 Sep; 37(9):1428-36. PubMed ID: 8790186
[TBL] [Abstract][Full Text] [Related]
26. FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? The Leuven Lung Cancer Group.
Vansteenkiste JF; Stroobants SG; Dupont PJ; De Leyn PR; De Wever WF; Verbeken EK; Nuyts JL; Maes FP; Bogaert JG
Eur J Nucl Med; 1998 Nov; 25(11):1495-501. PubMed ID: 9799345
[TBL] [Abstract][Full Text] [Related]
27. Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer.
Gupta NC; Graeber GM; Rogers JS; Bishop HA
Ann Surg; 1999 Feb; 229(2):286-91. PubMed ID: 10024112
[TBL] [Abstract][Full Text] [Related]
28. PET in lung cancer staging.
Coleman RE
Q J Nucl Med; 2001 Sep; 45(3):231-4. PubMed ID: 11788815
[TBL] [Abstract][Full Text] [Related]
29. [Positron emission tomography for detection of lymph node metastases in lung cancer].
Sugio K; Sasaki M; Yamazaki K; Kase S; Sugimachi K
Nihon Geka Gakkai Zasshi; 1999 Nov; 100(11):718-23. PubMed ID: 10629837
[TBL] [Abstract][Full Text] [Related]
30. FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer.
Ohtsuka T; Nomori H; Ebihara A; Watanabe K; Kaji M; Naruke T; Suemasu K; Uno K
Ann Thorac Cardiovasc Surg; 2006 Apr; 12(2):89-94. PubMed ID: 16702929
[TBL] [Abstract][Full Text] [Related]
31. PET versus PET/CT dual-modality imaging in evaluation of lung cancer.
Freudenberg LS; Rosenbaum SJ; Beyer T; Bockisch A; Antoch G
Radiol Clin North Am; 2007 Jul; 45(4):639-44, v. PubMed ID: 17706528
[TBL] [Abstract][Full Text] [Related]
32. Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma.
Patz EF; Lowe VJ; Goodman PC; Herndon J
Chest; 1995 Dec; 108(6):1617-21. PubMed ID: 7497771
[TBL] [Abstract][Full Text] [Related]
33. [Impact of computed tomography (CT) and 18F-deoxyglucose-coincidence detection emission tomography (FDG-CDET) image fusion for optimisation of conformal radiotherapy in non-small-cell lung cancers].
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Cancer Radiother; 2005 Sep; 9(5):304-15. PubMed ID: 16087377
[TBL] [Abstract][Full Text] [Related]
34. Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography.
Bury T; Dowlati A; Paulus P; Hustinx R; Radermecker M; Rigo P
Eur J Nucl Med; 1996 Feb; 23(2):204-6. PubMed ID: 8925857
[TBL] [Abstract][Full Text] [Related]
35. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer.
Cerfolio RJ; Ojha B; Bryant AS; Raghuveer V; Mountz JM; Bartolucci AA
Ann Thorac Surg; 2004 Sep; 78(3):1017-23; discussion 1017-23. PubMed ID: 15337041
[TBL] [Abstract][Full Text] [Related]
36. FDG PET: advantages for staging the mediastinum?
Franzius C
Lung Cancer; 2004 Aug; 45 Suppl 2():S69-74. PubMed ID: 15552784
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic value of dual time-point 18 F-FDG PET/CT versus single time-point imaging for detection of mediastinal nodal metastasis in non-small cell lung cancer patients: a meta-analysis.
Shen G; Hu S; Deng H; Jia Z
Acta Radiol; 2015 Jun; 56(6):681-7. PubMed ID: 24917609
[TBL] [Abstract][Full Text] [Related]
38. Multiple distant muscular metastases from non-small cell lung carcinoma evidenced by 18F-FDG PET/CT.
Caobelli F; Pizzocaro C; Guerra UP
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):338-9. PubMed ID: 23809515
[No Abstract] [Full Text] [Related]
39. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study.
Yoon YC; Lee KS; Shim YM; Kim BT; Kim K; Kim TS
Radiology; 2003 Jun; 227(3):764-70. PubMed ID: 12773680
[TBL] [Abstract][Full Text] [Related]
40. Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion.
Halpern BS; Schiepers C; Weber WA; Crawford TL; Fueger BJ; Phelps ME; Czernin J
Chest; 2005 Oct; 128(4):2289-97. PubMed ID: 16236886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
